Abstract
The differential diagnosis of widespread pain in older adults is broad, with fibromyaglia syndrome (FMS) leading the list. While the exact pathogenesis of FMS is not clear, recent studies suggest that abnormal pain processing and central sensitization contribute to the development of chronic muscle pain and tender points. Precise diagnosis of FMS requires a targeted history and physical examination. A multimodal treatment approach combining pharmacologic management, physical therapy, and cognitive behavioral techniques is effective for reducing pain and improving function and overall well-being. Antidepressant and anticonvulsant medications are widely used for FMS treatment. Depression and anxiety are common psychiatric comorbidities in older FMS patients that also require treatment to optimize outcomes.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Crook J, Rideout E, Brown G. The prevalence of pain complaints is a general population. Pain. 1984;18:299–314.
Anderson S, Worm-Pederson J. The prevalence of persistent pain in a Danish population. In: Proceedings of the Fifth World Congress on Pain: Pain Supplement. Seattle, WA: International Association for the Study of Pain 1987;4:S332.
Magni G, Marchetti M, Moreschi C, et al. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. Epidemiologic follow-up study. Pain. 1993;53(2):163–8.
Sengstaken EA, King SA. The problems of pain and its detection among geriatric nursing home residents. J Am Geriatr Soc. 1993;41(5):541–4.
Schick FL, Schick R. Growth of the older population, actual and projected, 1900–2050. Table A1–9, Statistical handbook on aging Americans. Phoenix, Arizona: Oryx Press; 1994.
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheum. 1990;33(2):160–72.
Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.
Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–99.
Wolfe F. The clinical syndrome of fibrositis. Am J Med. 1986;81(Suppl 3A):7–14.
Weir PT, Harlan GA, Nkoy FL. The incidence of fibromyalgia and its associated comorbidities. J Clin Rheumatol. 2006;12(3):124–8.
Yunus MB, Holt G, Masi AT, et al. Fibromyalgia syndrome among the elderly: Comparison with younger patients. J Am Geriatr Soc. 1998;36(11):987–95.
Cronan TA, Serber ER, Walen HR, et al. The influence of age on fibromyaglia symptoms. J Aging Health. 2002;14(3):370–84.
Corran TM, Farrell MJ, Helme RD, et al. The classification of patients with chronic pain: age as a contributing factor. Clin Journal of Pain. 1997;13(3):207–14.
Wright GE, Parker JC, Smarr KL, et al. Age, depressive symptoms, and rheumatoid arthritis. Arthritis Rheum. 1998;41(2):298–305.
Baumstark KE, Buckelew SP, Sher KJ, et al. Pain behavior predictors among fibromyalgia patients. Pain. 1993;55(3):339–46.
Yunus MB, Hold GS, Masi AT, et al. Fibromyalgia symptoms among the elderly: Comparison with younger patients. J Am Geriatr Soc. 1988;36:987–95.
Leveille SG, Ling S, Hochberg MC, et al. Widespread musculoskeletal pain and the progression of disability in older disabled women. Ann Intern Med. 2001;135(12):1038–46.
Leveille SG, Bean J, Bandeen-Roche K, et al. Musculoskeletal pain and risk for falls in older disabled women living in the community. J Am Geriatr Soc. 2002;50(4):671–8.
Leveille SG et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA. 2009;302(20):2214–21.
Geisser ME, Glass JM, Rajcevska LD, et al. A psychophysical study of auditory and pressure sensitivity with fibromyalgia and healthy controls. J Pain. 2008;9(5):417–22.
Staud R, Rodriguez ME. Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol. 2006;2(2):90–8.
Russel IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37(11):1593–601.
Vaeroy H, Helle R, Forre O, et al. Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 1998;32(1):21–6.
Welin M, Bragee B, Nyberg F, et al. Elevated substance P levels are contrasted by a decrease in met-enkephalin-arg-phe levels in CSF from fibromyalgia patients. J Musculoskelet Pain. 1995;3(suppl):4.
Bradley LA, Alberts KR, Alarcon GS, et al. Abnormal brain regional blood flow (fCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia (FM). Arthritis Rheum. 1996;39 suppl 19:212.
Giovengo SL, Russell IJ, Larson AA. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 1999;26(7):1564–9.
Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci. 1998;315(6):377–84.
Murphy RM, Zelman FP. Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacol (Berl). 1987;93(1):118–21.
Schwarz MJ, Spath M, Muller-Bardoff H, et al. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett. 1999;259(3):196–8.
Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis and Rheum. 1994;37(11):1583–92.
McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl. 1989;19:154–7.
Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993;20(3):469–74.
Tanriverdi F, Karaca Z, Unluhizarci K, et al. The hypothalamo-pituitary-adrenal axis in chronic fatigue and fibromyalgia syndrome. Stress. 2007;10(1):13–25.
Zhuo M, Gebhart GF. Spinal cholinergic and monoaminergic receptors mediate descending inhibition from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 1990;535(1):67–78.
Zimmerman ME, Brickman AM, Paul RH, et al. The relationship between frontal gray matter volume and cognition varies across the healthy adult lifespan. Am J of Geriatr Psychiatry. 2006;14(10):823–33.
Mitchell TW, Mufson EJ, Schneider JA, et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer’s disease. Ann Neurol. 2002;51(2):182–9.
Cole LJ, Farrell MJ, Duff PE, et al. Pain sensitivity and fMRI pain-related brain activity in Alzheimer’s disease. Brain. 2006;129:2957–65.
Benedetti F, Arduino C, Costa S, et al. Loss of expectation-related mechanisms in Alzheimers disease makes analgesic therapies less effective. Pain. 2006;121(1–2):133–44.
Herr KA, Mobily PR. Comparison of selected pain assessment tools for use with the elderly. Appl Nurs Res. 1993;6(1):39–46.
Karp JF, Weiner DK. Psychiatric care of the older adult with persistent pain. Eds: Maletta G, Argonon M. In: Principles and Practice of Geriatric Psychiatry, Chapter 42, New York: Lippincott Williams and Wilkins; 2006:657–76.
Weiner D, Peterson B, Keefe F. Evaluating persistent pain in long term care residents: What role for pain maps? Pain. 1998;76:249–57.
Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med. 2004;66(6):837–44.
MCBeth J, MacFarlane GJ, Benjamin S, et al. The association between tender points, psychological distress and adverse childhood experiences. Arthritis Rheum. 1999;42(7):1397–404.
Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50(3):944–52.
Pope Jr HG, Hudson JI. A supplemental interview for forms of affective spectrum disorder. Int J Psychiatry Med. 1991;21(3):205–32.
Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Phys Med Rehab Clin of North America. 2006;17:491–510.
Rosenson RS. Current overview of statin-induced myopathy. Am J Med. 2004;116:408–16.
Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression late in life. J Clin Psychiatry. 1999;60:9–15.
Cohen-Mansfield J, Marx MS. Pain and depression in the nursing home: corroborating results. J Gerontol. 1993;48(2):P96–7.
Jongenelis K, Pot AM, Eisses A, et al. Prevalence and risk indicators of depression in elderly nursing home patients: the AGED study. J Affect Disord. 2004;83(2–3):135–42.
Lyness JM, Bruce ML, Koenig HG, et al. Depression and medical illness in late life: report of symposium. J Am Geriatr Soc. 1996;44(2):198–203.
Lyness JM, Caine ED, King DA, et al. Psychiatric disorders in older primary care patients. J Gen Intern Med. 1999;14(4):249–54.
Lenze EJ, Mulsant BH, Shear MK, et al. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry. 2000;157(5):722–8.
Mulsant BH, Reynolds CF, Shear MK, et al. Comorbid anxiety disorders in late-life depression. Anxiety. 1996;2(5):242–7.
Parmelee P, Katz IR, Lawton MP. Anxiety and its association with depression among institutionalized elderly. Am J Geriatr Psychiatry. 1993;1:65–78.
Wolfe F, Hawley DJ. Psychosocial factors and the fibromyalgia syndrome. Z Rheumatol. 1998;57 Suppl 2:88–91.
White KP, Nielson WR, Harth M, et al. Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol. 2002;29(3):588–94.
Arnold LM, Lu Y, Crofford LJ, et al. A double blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50(9):2974–84.
Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with or without major depressive disorder. Pain. 2005;119(1–3):5–15.
Arnold LM, Keck PE. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000;41(2):104–13.
Maizels M, McCarberg B. Antidepressant and antiepileptic drugs for the chronic non-cancer pain. Am Fam Physician. 2005;71(3):483–90.
O’Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med. 2000;15(9):659–66.
Carette S, McCain GA, Bell DA, et al. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum. 1986;29(5):655–9.
Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 1986;29(11):1371–7.
Santandrea S, Montrone F, Sarzi-Puttini P, et al. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res. 1993;21(2):74–80.
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–6.
Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–32.
Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23(5):255–9.
Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39(11):1852–9.
Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia – a randomized, double-blind, placebo-controlled study. Eur J Pain. 2000;4(1):27–35.
Karp J, Whyte E, Lenze E, et al. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability. J Clin Psychiatry. 2008;69(3):457–63.
Raskin J, Wiltse CG, Dinkel JJ. Safety and tolerability of duloxetine at 60mg once daily in elderly patients with major depressive disorder. J Clin Psychopharmacol. 2008;28(1):32–8.
Wohlreich MM, Mallinckrodt CH, Prakash A, et al. Duloxetine for the treatment of major depressive disorder in patients aged 65 and older: an open-label study. BMC Geriatr. 2004;7:4–11.
Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed dose trial. Pain. 2008;136(3):432–44.
Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32(10):1975–85.
Mease PJ et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(2):398–409.
Dwight MM, Arnold LM, O’Brien H, et al. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics. 1998;39(1):14–7.
Zijlstra TR, Barendregt P, van De Laar MA. Venlafaxine in fibromyalgia: results of a randomized placebo-controlled, double-blind trial. Eur J Pain. 2000;4(1):27–35.
Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008;136(3):419–31.
Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56(4):1336–44.
Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27:10000–6.
Bennett RM, Kamin M, Karim R, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, placebo-controlled study. Am J Med. 2003;114(7):537–45.
Dew MA, Hoch CC, Buysse DJ, et al. Healthy older adults’ sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65(1):63–73.
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292(19):2388–95.
Burckhart CS. Nonpharmacologic management strategies in fibromyalgia. Rheum Dis Clin North Am. 2002;28(2):291–304.
Jones KD, Clark SR. Individualizing the exercise prescription for persons with fibromyalgia. Rheum Dis Clin North Am. 2002;28(2):419–36.
Martin DP, Sletten CD, Williams BA, et al. Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc. 2006;81(6):749–57.
Deluze C, Bosia L, Zirbs A. Electroacupunture in fibromyalgia: results of a controlled trial. BMJ. 1992;305(6864):1249–52.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bernstein, C.D., Karp, J.F., Weiner, D.K. (2011). Widespread Pain in Older Adults. In: Nakasato, Y., Yung, R. (eds) Geriatric Rheumatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5792-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5792-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5791-7
Online ISBN: 978-1-4419-5792-4
eBook Packages: MedicineMedicine (R0)